- Home
- ATSG vs NVAX Comparison
ATSG vs NVAX Comparison
Compare ATSG & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATSG
- NVAX
- Stock Information
- Founded
- ATSG 1980
- NVAX 1987
- Country
- ATSG United States
- NVAX United States
- Employees
- ATSG N/A
- NVAX N/A
- Industry
- ATSG Air Freight/Delivery Services
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATSG Consumer Discretionary
- NVAX Health Care
- Exchange
- ATSG Nasdaq
- NVAX Nasdaq
- Market Cap
- ATSG 1.5B
- NVAX 1.3B
- IPO Year
- ATSG N/A
- NVAX 1995
- Fundamental
- Price
- ATSG N/A
- NVAX $6.00
- Analyst Decision
- ATSG Buy
- NVAX Buy
- Analyst Count
- ATSG 5
- NVAX 6
- Target Price
- ATSG $20.60
- NVAX $17.83
- AVG Volume (30 Days)
- ATSG 1.7M
- NVAX 6.0M
- Earning Date
- ATSG 05-05-2025
- NVAX 05-09-2025
- Dividend Yield
- ATSG N/A
- NVAX N/A
- EPS Growth
- ATSG N/A
- NVAX N/A
- EPS
- ATSG 0.40
- NVAX N/A
- Revenue
- ATSG $1,961,971,000.00
- NVAX $682,162,000.00
- Revenue This Year
- ATSG $7.04
- NVAX $1.07
- Revenue Next Year
- ATSG $4.43
- NVAX N/A
- P/E Ratio
- ATSG $55.54
- NVAX N/A
- Revenue Growth
- ATSG N/A
- NVAX N/A
- 52 Week Low
- ATSG $11.69
- NVAX $3.81
- 52 Week High
- ATSG $22.49
- NVAX $23.86
- Technical
- Relative Strength Index (RSI)
- ATSG 1.00
- NVAX 41.41
- Support Level
- ATSG $21.98
- NVAX $5.01
- Resistance Level
- ATSG $22.47
- NVAX $6.58
- Average True Range (ATR)
- ATSG 0.06
- NVAX 0.65
- MACD
- ATSG -2.64
- NVAX 0.02
- Stochastic Oscillator
- ATSG 0.00
- NVAX 50.25
About ATSG Air Transport Services Group Inc
Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.